Get the tools used by (smart)2 investors.

Merck & Co., Inc.BRSE:010683053

United States / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
84.60 CHF
Price
2.34 (2.85%)
Day change
74.12 - 120.16
52-week range

Summary of Merck & Co., Inc.

Hide this widget

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers h...

Dec 31, 2024
Latest Report
Apr 24, 2025
Next Earnings
Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  010683053 Peers Sector
Market Cap
196.5 B30.94 B57.748 M
Price % of 52 Week High
-75.2%62.3%
Dividend Yield
3.4%0.0%0.0%
Shareholder Yield
3.1%1.3%-0.7%
1 Year Price Total Return
-19.9%-5.0%-11.0%
Beta (5 Year)
0.360.600.64

In the News

Hide this widget

Data could not be retrieved

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
CHF
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for Merck is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.

Financial Models for Merck & Co., Inc.

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue54,81250,56258,22512,30514,177
Operating Income18,94513,43522,584(550)4,846
Net Profit13,42430715,532(1,031)3,396
Diluted EPS5.280.126.12-0.411.34
EBITDA22,44816,57426,4362095,857
Balance Sheet
Cash & ST Invest.12,1975,96612,4215,96612,421
Current Assets33,02827,05635,19027,05635,190
Total Assets100,92889,722106,26189,722106,261
Current Liabilities22,41121,61125,78821,61125,788
Total Liabilities58,34358,06864,18358,06864,183
Total Equity42,58531,65442,07731,65442,077
Total Debt29,57330,50434,72630,50434,726
Cash Flow Statement
Cash Flow Operations17,65510,93919,4802073,130
Cash From Investing(4,586)(11,845)(7,018)45(1,310)
Cash From Financing(8,431)(4,046)(6,381)(1,888)(2,730)
Free Cash Flow13,5987,69016,420(625)2,280

Analyst Notes

March 27, 2025
Hide this widget
    All rights reserved. Terms Of Use